512 results on '"Shi, Jialan"'
Search Results
2. Damage to endothelial barriers and its contribution to long COVID
3. Endothelium dysfunction and thrombosis in COVID-19 with type 2 diabetes
4. ABL1 kinase plays an important role in spontaneous and chemotherapy-induced genomic instability in multiple myeloma
5. Reply to “Embracing imatinib: a novel approach to safeguarding the endothelial barrier in patients with COVID-19”
6. Elevated APE1 Dysregulates Homologous Recombination and Cell Cycle Driving Genomic Evolution, Tumorigenesis, and Chemoresistance in Esophageal Adenocarcinoma
7. Membrane curvature and PS localize coagulation proteins to filopodia and retraction fibers of endothelial cells
8. TMEM16F mediated phosphatidylserine exposure and microparticle release on erythrocyte contribute to hypercoagulable state in hyperuricemia
9. CD44–fibrinogen binding promotes bleeding in acute promyelocytic leukemia by in situ fibrin(ogen) deposition
10. Phagocytosis by endothelial cells inhibits procoagulant activity of platelets of essential thrombocythemia in vitro
11. ABL1 kinase plays an important role in spontaneous and chemotherapy-induced genomic instability in multiple myeloma
12. Integrated genomics and comprehensive validation reveal drivers of genomic evolution in esophageal adenocarcinoma
13. Dysregulated APOBEC3G causes DNA damage and promotes genomic instability in multiple myeloma
14. P-215 Apurinic/apyrimidinic nuclease 1 (APEX1) can impact multiple related pathways to drive growth and genomic instability in myeloma
15. Phosphatidylserine-exposing blood cells and microparticles induce procoagulant activity in non-valvular atrial fibrillation
16. Intravascular cells and circulating microparticles induce procoagulant activity via phosphatidylserine exposure in heart failure
17. Neutrophil extracellular traps enhance procoagulant activity in patients with oral squamous cell carcinoma
18. Damage to endothelial barriers and its contribution to long COVID
19. Promyelocytic extracellular chromatin exacerbates coagulation and fibrinolysis in acute promyelocytic leukemia
20. Microparticles and blood cells induce procoagulant activity via phosphatidylserine exposure in NSTEMI patients following stent implantation
21. Phosphatidylserine-exposing blood and endothelial cells contribute to the hypercoagulable state in essential thrombocythemia patients
22. Microparticle Phosphatidylserine Mediates Coagulation: Involvement in Tumor Progression and Metastasis
23. The intersection of obesity and (long) COVID-19: Hypoxia, thrombotic inflammation, and vascular endothelial injury
24. Platelet binding sites for factor VIII in relation to fibrin and phosphatidylserine
25. RAD51 Is Implicated in DNA Damage, Chemoresistance and Immune Dysregulation in Solid Tumors
26. Pathophysiological mechanisms of thrombosis in acute and long COVID-19
27. Flap Structure-Specific Endonuclease 1 Coordinates with a Helicase (ASCC3) to Drive Genomic Instability, Proliferation and Poor Clinical Outcome in Myeloma
28. Exonuclease 1 Drives Growth and Genomic Instability in Multiple Myeloma through Interaction with CAD, a Key Protein Involved in De Novo Pyrimidine Biosynthesis
29. Early antithrombotic therapy for another highly lethal viral pneumonia pandemic
30. Enhanced Procoagulant Activity on Blood Cells after Acute Ischemic Stroke
31. Early antithrombotic therapy for another highly lethal viral pneumonia pandemic
32. The impact of platelets on pulmonary microcirculation throughout COVID-19 and its persistent activating factors
33. The cross-talk of lung and heart complications in COVID-19: Endothelial cells dysfunction, thrombosis, and treatment
34. Arsenic trioxide promoting ETosis in acute promyelocytic leukemia through mTOR-regulated autophagy
35. Chemotherapy induces enhanced procoagulant activity through phosphatidylserine exposure in acute lymphoblastic leukemia
36. ABL1 Kinase plays an important role in spontaneous and chemotherapy-induced genomic instability in multiple myeloma
37. Apurinic/apyrimidinic nuclease 1 drives genomic evolution contributing to chemoresistance and tumorigenesis in solid tumor
38. Extracellular Traps Increase Burden of Bleeding by Damaging Endothelial Cell in Acute Promyelocytic Leukaemia
39. Persistent Lung Injury and Prothrombotic State in Long COVID
40. Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation
41. Phagocytosis by macrophages and endothelial cells inhibits procoagulant and fibrinolytic activity of acute promyelocytic leukemia cells
42. Intestinal Damage in COVID-19: SARS-CoV-2 Infection and Intestinal Thrombosis
43. Thrombosis and hemorrhage in myeloproliferative neoplasms: The platelet perspective
44. Circulating Microparticles in the Pathogenesis and Early Anticoagulation of Thrombosis in COVID-19 With Kidney Injury
45. The Central Role of Extracellular Vesicles in the Mechanisms of Thrombosis in COVID-19 Patients With Cancer and Therapeutic Strategies
46. Neutrophil extracellular traps induced by pro-inflammatory cytokines enhance procoagulant activity in NASH patients
47. Membrane Phosphatidylserine Regulates Surface Charge and Protein Localization
48. Arsenic trioxide induces procoagulant activity through phosphatidylserine exposure and microparticle generation in endothelial cells
49. Review on development and application of SOC key technologies for electric vehicle battery packs
50. Homocysteine induces procoagulant activity of red blood cells via phosphatidylserine exposure and microparticles generation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.